controversy News
Most Popular controversy Story
Gene therapy makes a big comeback
After running into a buzzsaw of controversy over the safety of gene therapy studies, the Los Angeles Times notes that the field has made a big comeback. There are currently more than 300 gene therapy trials underway and solid evidence that the approach can help patients with Parkinson's and other lethal immune disorders. Gene therapy works by replacing the faulty genes that cause the disorders with healthy ones.
- read the The Los Angeles Times report on gene therapy
Latest Headlines
- March 28, 2008
- March 7, 2008
- March 4, 2008
- January 30, 2008
- January 17, 2008
- January 7, 2008
- September 5, 2007
- September 4, 2007
- June 25, 2007
- January 9, 2007
- December 19, 2006
- November 2, 2006
- October 18, 2006
- September 17, 2006
- August 27, 2006
- August 23, 2006
- August 16, 2006
- August 1, 2006
- July 31, 2006
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
